Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology 1994: Vol 33 Index

4 Pages·1994·1.2 MB·English

Fe aviotHerapy
© Ovcotosy
SBR 45%
ELSEVIER
Radiotherapy and Oncology 33 (1994) 282-283
Author index
Volume 33 (1994)
A’Hern, R.P., see Moody, A.M. 33, 106 Dubben, H.-H., see Beck-Bornholdt, H.-P. 33, 171
Abe, M., see Hiraoka, M. 33, 48 Dubray, B.M., H.D. Thames, Chronic radiation damage in the rat rec-
Aletti, P., see Kharrati, H. 33, 80 tum: an analysis of the influences of fractionation, time and
Althof, V.G.M.,se e van’t Riet, A. 33, 167 volume 33, 41
Ashley, S., see Thomas, R. 33, 113
Fife, K., S. Milan, K. Westbrook, R. Powles, D. Tait, Risk factors for
Barber, P.V., see Gollins, S.W. 33, 31 requiring cataract surgery following total body irradiation/#33, 93
Flentje, M., see Rudat, V. 33, 56
Beauvois, S., S. Hoffstetter, D. Peiffert, E. Luporsi, J.M. Carolus, D.
Fossa, S.D., see Yao, W.Q. 33, 88
Dartois, M. Pernot, Brachytherapy for lower lip epidermoid cancer:
Fuks, Z., see Ling, C.C. 33, 17
tumoral and treatment factors influencing recurrences and com-
plications 33, 195
Gerard, J.-P., see Mahe, M. 33, 204
Beck-Bornholdt, H.-P., H.-H. Dubben, Potential pitfalls in the use of
Gillies McKenna, W., see D’Amico, A.V. 33, 3
p-values and in interpretation of significance levels 33, 171
Gollins, S.W., P.A. Burt, P.V. Barber, R. Stout, High dose rate intra-
Begg, A.C., see Smeets, M.F.M. 33, 217
luminal radiotherapy for carcinoma of the bronchus: outcome of
Bjarngard, B.E., see Tatcher, M. 33, 64
treatment of 406 patients 33, 31
Bliss, J.M., see Moody, A.M. 33, 106
Gregor, A., see Thomas, R. 33, 113
Blomquist, E., see Grusell, E. 33, 68
Grusell, E., A. Montelius, K.R. Russell, E. Blomquist, L. Pellettieri,
Bliiml, S., see Schad, L.R. 33, 73
A. Lilja, U. Mostrém, P. Jakobsson, Patient positioning for frac-
Brada, M., see Thomas, R. 33, 113
tionated precision radiation treatment of targets in the head using
Brizel, D.M., R. Dodge, M.W. Dewhirst, The effect of the perflubron
fiducial markers 33, 68
emulsion Oxygent™ on the calibration characteristics of
Guerrero, D., see Thomas, R. 33, 113
polarographic oxygen electrodes 33, 262
Guillemin, F., see Kharrati, H. 33, 80
Broad, B., see Moody, A.M. 33, 106
Bui, B.N., see Thomas, L. 33, 99
Hamilton, C.S., see Ostwald, P.M. 33, 148
Burnet, N.G., J. Nyman, I. Turesson, R. Wurm, J.R. Yarnold, J.H.
Hendry, J.H., T.-N. Jiang, Differential radiosensitising effect of the
Peacock, The relationship between cellular radiation sensitivity and
scid mutation among tissues, studied using high and low dose rates:
tissue response may provide the basis for individualising
implications for prognostic indicators in radiotherapy 33, 209
radiotherapy schedules 33, 228
Hiraoka, M., M. Mitsumori, K. Okajima, Y. Nagata, M. Takahashi,
Burt, P.A., see Gollins, S.W. 33, 31
M. Nakata, M. Abe, Use of a CT simulator in radiotherapy treat-
ment planning for breast conserving therapy 33, 48
Carolus, J.M., see Beauvois, S. 33, 195
Hoekstra, C.J.M., see van’t Riet, A. 33, 167
Chen, C.H., see Ling, C.C. 33, 17
Hoffstetter, S., see Beauvois, S. 33, 195
Chevreau, C., see Thomas, L. 33, 99
Holmberg, O., H. Huizenga, M.H.M. Idzes, J.V. Lebesque, R.E. Vi-
Cooper, S.G., see Ostwald, P.M. 33, 148
jlbrief, B.J. Mijnheer, In vivo determination of the accuracy of field
Court, J.B., S.K. Salman, I.J. Kerby, The prognostic significance of
matching in breast cancer irradiation using an electronic portal im-
hyperploid cells in squamous carcinoma of the uterine cervix treated
aging device 33, 157
with radiotherapy 33, 266
Horwich, A., see Yao, W.Q. 33, 88
Huizenga, H., see Holmberg, O. 33, 157
D’Amico, A.V., W. Gillies McKenna, Apoptosis and a re-investiga-
Hunter, N.R., see Mirkovic, N. 33, 11
tion of the biologic basis for cancer therapy 33, 3
Dale, R.G., B. Jones, The effect of tumour shrinkage on biologically Idzes, M.H.M., see Holmberg, O. 33, 157
effective dose, and possible implications for fractionated high dose
rate brachytherapy 33, 125 Jakobsson, P., see Grusell, E. 33, 68
Daly-Schveitzer, N., see Thomas, L. 33, 99 James, N., see Thomas, R. 33, 113
Dartois, D., see Beauvois, S. 33, 195 Jiang, T.-N., see Hendry, J.H. 33, 209
Dearnaley, D., see Lee, M. 33, 239 Jones, B., see Dale, R.G. 33, 125
Dearnaley, D.P., see Yao, W.Q. 33, 88 Jones, G., see Wright, J. 33, 187
Debus, J., see Schad, L.R. 33, 73
Delannes, M., see Thomas, L. 33, 99 Kantor, G., see Thomas, L. 33, 99
Denham, J.W., see Ostwald, P.M. 33, 148 Kerby, I.J., see Court, J.B. 33, 266
Dewhirst, M.W., see Brizel, D.M. 33, 262 Kharrati, H., P. Aletti, F. Guillemin, Design of a non-docking in-
Dodge, R., see Brizel, D.M. 33, 262 traoperative electron beam applicator system 33, 80
Dorr, W., Repopulation in mouse oral mucosa: treatment splits 33, Koper, P.C.M., see Logmans, A. 33, 269
139 Kouvaris, J., see Plataniotis, G. 33, 84
Author index /R adiother. Oncol. 33 (1994) 282-283
Latz, D., see Schraube, P. 33, 254 Romestaing, P., see Mahe, M. 33, 204
Lebesque, J.V., see Holmberg, O. 33, 157 Rudat, V., M. Flentje, D. Oetzel, M. Menke, W. Schlegel, M. Wan-
Lee, M., C. Wynne, S. Webb, A.E. Nahum, D. Dearnaley, A com- nenmacher, Influence of the positioning error on 3D conformal dose
parison of proton and megavoltage X-ray treatment planning for distributions during fractionated radiotherapy 33, 56
prostate cancer 33, 239 Russell, K.R., see Grusell, E. 33, 68
Lilja, A., see Grusell, E. 33, 68
Ling, C.C., C.H. Chen, Z. Fuks, An equation for the dose response Salerno, N., see Mahe, M. 33, 204
of radiation-induced apoptosis: possible incorporation with the LQ Salman, S.K., see Court, J.B. 33, 266
Schad, L.R., S. Bliiml, J. Debus, J. Scharf, W.J. Lorenz, Improved tar-
model 33, 17
Logmans, A., M. van Lent, A.N. van Geel, M. Olofsen-Van Acht, get volume definition for precision radiotherapy planning of men-
P.C.M. Koper, Th. Wiggers, J.B. Trimbos, The pedicled omen- ingiomas by correlation of CT and dynamic, Gd-DTPA-enhanced
toplasty, a simple and effective surgical technique to acquire a safe FLASH MR imaging 33, 73
pelvic radiation field; theoretical and practical aspects 33, 269 Scharf, J., see Schad, L.R. 33, 73
Lorenz, W.J., see Schad, L.R. 33, 73 Schlegel, W., see Rudat, V. 33, 56
Lukka, H., see Wright, J. 33, 187 Schraube, P., D. Latz, M. Wannenmacher, Treatment of primary
Luporsi, E., see Beauvois, S. 33, 195 squamous cell carcinoma of the trachea: the role of radiation thera-
py 33, 254
Mahe, M., C. Stampfli, P. Romestaing, N. Salerno, J.-P. Gerard, Pri- Skowronska-Gardas, A., Hyperfractionated radiotherapy for brain
mary carcinoma of the gall-bladder: potential for external radiation stem tumours in children 33, 259
therapy 33, 204 Smeets, M.F.M., E.H.M. Mooren, A.C. Begg, The effect of radiation
Mak, A.C.A., see van’t Riet, A. 33, 167 on G, blocks, cyclin B expression and cdc2 expression in human
Martel, P., see Thomas, L. 33, 99 squamous carcinoma cell lines with different radiosensitivities 33,
Mayles, W.P.M., see Moody, A.M. 33, 106 217
Menke, M., see Rudat, V. 33, 56 Stampfli, C., see Mahe, M. 33, 204
Meyn, R.E., see Mirkovic, N. 33, 11 Stéckle, E., see Thomas, L. 33, 99
Michalopoulos, E., see Plataniotis, G. 33, 84 Stout, R., see Gollins, S.W. 33, 31
Mijnheer, B.J., see Holmberg, O. 33, 157
Milan, S., see Fife, K. 33, 93 Tait, D., see Fife, K. 33, 93
Milas, L., see Mirkovic, N. 33, 11 Takahashi, M., see Hiraoka, M. 33, 48
Mirkovic, N., R.E. Meyn, N.R. Hunter, L. Milas, Radiation-induced Tatcher, M., B.E. Bjarngard, Head-scatter factors in blocked photon
apoptosis in a murine lymphoma in vivo 33, 11 fields 33, 64
Mitsumori, M., see Hiraoka, M. 33, 48 te Loo, H.J., see van’t Riet, A. 33, 167
Montelius, A., see Grusell, E. 33, 68 Thames, H.D., see Dubray, B.M. 33, 41
Moody, A.M., W.P.M. Mayles, J.M. Bliss, R.P. A’Hern, J.R. Owen, Thomas, L., M. Delannes, E. Stéckle, P. Martel, B.N. Bui, N. Daly-
J. Regan, B. Broad, J.R. Yarnold, The influence of breast size on Schveitzer, J. Pigneux, C. Chevreau, G. Kantor, Intraoperative in-
late radiation effects and association with radiotherapy dose in- terstitial iridium brachytherapy in the management of soft tissue
homogeneity 33, 106 sarcomas: preliminary results of a feasibility Phase II study 33, 99
Mooren, E.H.M., see Smeets, M.F.M. 33, 217 Thomas, R., N. James, D. Guerrero, S. Ashley, A. Gregor, M. Brada,
Mostrém, U., see Grusell, E. 33, 68 Hypofractionated radiotherapy as palliative treatment in poor prog-
Mullen, J.R., G.K. Zagars, Synovial sarcoma outcome following con- nosis patients with high grade glioma 33, 113
servation surgery and radiotherapy 33, 23 Trimbos, J.B., see Logmans, A. 33, 269
Turesson, I., see Burnet, N.G. 33, 228
Turesson, I., see Nyman, J. 33, 117
Nagata, Y., see Hiraoka, M. 33, 48
Nahum, A.E., see Lee, M. 33, 239
Nakata, M., see Hiraoka, M. 33, 48 van Geel, A.N., see Logmans, A. 33, 269
Nyman, J., I. Turesson, Basal cell density in human skin for various van Lent, M., see Logmans, A. 33, 269
fractionation schedules in radiotherapy 33, 117 van’t Riet, A., A.C.A. Mak, H.J. te Loo, C.J.M. Hoekstra, V.G.M.
Nyman, J., see Burnet, N.G. 33, 228 Althof, Verification of source position in interstitial and in-
tralumenal brachytherapy 33, 167
Oetzel, D., see Rudat, V. 33, 56 Vijlbrief, R.E., see Holmberg, O. 33, 157
Okajima, K., see Hiraoka, M. 33, 48 Vlahos, L., see Plataniotis, G. 33, 84
Olofsen-Van Acht, M., see Logmans, A. 33, 269
Ostwald, P.M., S.G. Cooper, J.W. Denham, C.S. Hamilton, Wannenmacher, M., see Rudat, V. 33, 56
Dosimetry of high energy electron therapy to the parotid Wannenmacher, M., see Schraube, P. 33, 254
Webb, S., see Lee, M. 33, 239
region 33, 148
Owen, J.R., see Moody, A.M. 33, 106 Westbrook, K., see Fife, K. 33, 93
Whelan, T., see Wright, J. 33, 187
Papavasiliou, C., see Plataniotis,G. 33, 84 Wiggers, Th., see Logmans, A. 33, 269
Peacock, J.H., see Burnet, N.G. 33, 228 Wright, J.,G. Jones, T. Whelan, H. Lukka, Patient preference for high
or low dose rate brachytherapy in carcinoma of the cervix 33, 187
Peiffert, D., see Beauvois, S. 33, 195
Wurm, R., see Burnet, N.G. 33, 228
Pellettieri, L., see Grusell, E. 33, 68
Pernot, M., see Beauvois, S. 33, 195 Wynne, C., see Lee, M. 33, 239
Pigneux, J., see Thomas, L. 33, 99
Yao, W.Q., S.D. Fossa, D.P. Dearnaley, A. Horwich, Combined sin-
Plataniotis, G., E. Michalopoulos, J. Kouvaris, L. Vlahos, C.
Papavasiliou, A _ feasibility study of partially accelerated gle course carboplatin with radiotherapy in treatment of Stage
radiotherapy for invasive bladder cancer 33, 84 IIA,B seminoma — a preliminary report 33, 88
Yarnold, J.R., see Burnet, N.G. 33, 228
Powles, R., see Fife, K. 33, 93
Yarnold, J.R., see Moody, A.M. 33, 106
Regan, J., see Moody, A.M. 33, 106
Rofstad, E.K., Fractionation sensitivity (a/8 ratio) of human Zagars, G.K., see Mullen, J.R. 33, 23
melanoma xenografts 33, 133
Fe apiotHERAPy
© Ocorosy
Radiotherapy and Oncology 33 (1994) 284-285
Subject index
Volume 33 (1994)
a/B ratio 33, 133 Fibroblast radiosensitivity 33, 228
Accelerated fractionation 33, 117 Fiducial markers 33, 68
Accelerated radiotherapy 33, 84 Field matching 33, 157
Accuracy 33, 157 Flow cytometry 33, 217
Anthropomorphic phantom 33, 148 Fractionated radiotherapy 33, 117
Antisense therapy 33, 3 Fractionation 33, 139
Apoptosis 33, 3, 11, 17 Fractionation sensitivity 33, 41, 133
Barthel index 33, 113 G, delay 33, 217
Basal cell density 33, 117 Gall-bladder carcinoma 33, 204
bel-2 33, 3
Biologically effective dose 33, 125 Headscatter 33, 64
Bladder cancer 33, 84 High dose rate brachytherapy 33, 125
Bone marrow transplant 33, 93 High precision radiotherapy 33, 73
Brachytherapy 33, 167, 187, 195, 254 Hyperfractionation 33, 259
Brain targets 33, 68 Hyperploid cells 33, 266
Brain stem tumours 33, 259 Hypoxia 33, 11
Breast cancer 33, 48, 106, 157
Breast conserving therapy 33, 48 Immunofluorescence 33, 217
Bronchus 33, 31 Interstitial implant 33, 99
Intraluminal radiotherapy 33, 31
Cancer therapy 33, 3 Intraoperative 33, 99
Carboplatin 33, 88 Intraoperative radiotherapy 33, 80
Carcinoma 33, 31 Ionizing radiation 33, 217
Cataract 33, 93 Iridium-192 33, 195
ede2 33, 217
Cell cycle 33, 217 Karnofsky performance status 33, 113
Cervix 33, 266
Cervix cancer 33, 187 Large nuclei 33, 266
Children 33, 259 Late radiation effect 33, 106
Collimation system 33, 80 Linear accelerator 33, 80
Comparative planning 33, 239 Linear quadratic equation 33, 17
Computed tomography 33, 48 Linear-quadratic model 33, 41
Conformal dose distributions 33, 239 Linear — quadratic 33, 125
Conformal radiotherapy 33, 56 Lip cancer 33, 195
Conservation surgery 33, 23 Local control 33, 23, 99
CT simulator 33, 48 Lymphoma _ 33, 11
Cyclins 33, 217
Magnetic resonance imaging 33, 73
Disabled patients 33, 113 Malignant melanoma 33, 133
Dose calculations 33, 64 Meningiomas 33, 73
Dose rate 33, 187 Mouse 33, 139
Multiple nuclei 33, 266
Early relapse 33, 266 Multiple testing 33, 171
Elderly patients 33, 113 Multivariate analysis 33, 171
Electron beam 33, 80
Electron beam radiotherapy 33, 148 Normal tissue 33, 139
Endobronchial brachytherapy 33, 31 Normal tissue injury 33, 41
Epithelium 33, 139 Normal tissue response 33, 228
Erythema 33, 117
External radiation therapy 33, 204 Omentoplasty 33, 269
Subject index /R adiother. Oncol. 33 (1994) 284-285 285
Oral mucositis 33, 139 Rat 33, 41
Oxygen measurement 33, 262 Rectum 33, 41
Oxygent 33, 262 Repair kinetics 33, 41
Repopulation 33, 41
p-value 33, 171
Palliation 33, 31 Scid syndrome 33, 209
Patient positioning 33, 68 Seminoma 33, 88
Patient positioning error 33, 56 SF, 33, 133
Patient preference 33, 187 Shielding blocks 33, 64
Pelvic tumors 33, 269 Significance level 33, 171
Perflubron 33, 262 Single fraction 33, 31
Phase II study 33, 113 Skin reactions 33, 117
Planning algorithms 33, 148 Soft tissue sarcomas 33, 99
Portal imaging 33, 157 Split dose 33, 11
Predictive assay 33, 133 Squamous cell carcinoma 33, 254
Predictive assays 33, 209 Stereotaxy 33, 73
Prognostic indicators 33, 209 Suramin 33, 3
Protein kinases 33, 217 Synovial sarcoma 33, 23
Proton therapy 33, 239
Thermoluminescence dosimetry 33, 148
Quality assurance 33, 157, 167 Total body irradiation 33, 93
Trachea 33, 254
Radiation 33, 11, 17, 41 Tumor control probability 33, 56
Radiation enteritis 33, 269 Tumour shrinkage 33, 125
Radiosensitivity 33, 209, 217
Radiotherapy 33, 48, 88, 139, 187, 228, 254, 259 Verification imaging 33, 167
Radiotherapy dose inhomogeneity 33, 106
Radiotherapy treatment planning 33, 48 Wound complication 33, 99